How patient-focused are pharma companies' access efforts?

Financial Post covers the Access to Medicine Foundation’s latest report, which addresses how some of the major pharma companies are reaching patients worldwide in pursuit of health equity, especially in low- and middle-income countries (LMICs)

The article discusses the Access to Medicine Foundation's latest report, which assesses the commitments and measurement approaches used by major pharmaceutical companies to reach patients.

It outlines the report’s findings, indicating that 19 of the 20 companies assessed have reported employing methods to monitor the patients they serve with essential medicines in LMICs. Additionally, it highlights substantial opportunities for these companies to enhance their commitments and improve their efforts to assist those in need.

Jayasree K. Iyer, CEO of the Foundation, is quoted: “We have seen that the pharmaceutical industry is making ambitious commitments to reach more patients worldwide. However, this report reveals that there is still much work to be done in achieving meaningful impact and calls for urgent steps to ensure lifesaving products reach every patient, everywhere.”